相关实验视频

Updated: Mar 14, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

通过NIHSS-ASPECTS分层的内血管血栓切除术后的再输血依赖结果临床核心不匹配

Felix Schlicht¹, Lukas Meyer¹, Gabriel Broocks²

¹Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Annals of clinical and translational neurology

|March 13, 2026

概括

成功的再输血显著改善了中风患者的功能结果,特别是那些临床症状 (NIHSS) 和核心心脏病发作大小 (ASPECTS) 之间高度不匹配的患者. 这支持机械血栓切除术的个性化治疗.

科学领域:

神经学神经学
干预性放射学干预性放射学
公共卫生公共卫生

背景情况:

机械血栓切除术 (MT) 是急性缺血性中风的关键治疗方法.
使用国家卫生研究院中风量表 (NIHSS) 和阿尔伯塔中风计划早期CT评分 (ASPECTS) 评估临床核心不匹配对于MT选择至关重要.
多中心注册表数据为评估治疗效果提供了强有力的证据.

研究的目的:

评估成功的再注射对MT后的功能结果的影响.
根据NIHSS和ASPECTS的录取来分层这些影响,作为临床核心不匹配的替代品.
确定从再输血中受益最多的患者子组.

主要方法:

从德国中风登记处 (2015-2023) 追溯分析了5448名前部循环中风患者接受MT的病例.
患者按ASPECTS (10; 9-8; ≤7) 和NIHSS (0-10; 11-15; ≥16) 分为9个分组.
主要终点:90天后的良好功能结果 (修改的兰金尺度[mRS]0-2);使用反向概率加权回归调整 (IPWRA) 进行分析.

主要成果:

成功的再注射 (mTICI 2b-3) 改善了所有NIHSS和ASPECTS子组的功能结果.
在高临床核心不匹配 (ASPECTS=10;NIHSS ≥16) 的患者中,观察到的最大益处是mTICI 3的良好结果增加了38个百分点.
与mTICI 2b相比,mTICI 3再通道产生了更好的结果,特别是在高NIHSS和高ASPECTS的患者中.

结论:

具有显著的临床核心不匹配的患者经历了成功的再注射的最实质性的功能收益.
这些发现强调了个性化治疗策略和精细的MT选择标准的重要性.
成功的再注射对各种患者个人资料都有好处,倡导采用量身定制的方法更广泛地应用.

关键词:

临床-核心不匹配美国国家卫生研究院的中风大小.转流是指转流的意思,是指转流的意思.一次性中风中风中风中风中风进行血栓切除术 (thrombectomy).

更多相关视频

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

相关概念视频

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...